Austrália - inglês - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - alendronate sodium,calcium carbonate,colecalciferol,microcrystalline cellulose -

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - colecalciferol, quantity: 0.14 mg; alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg) - tablet, uncoated - excipient ingredients: gelatin; croscarmellose sodium; butylated hydroxytoluene; colloidal anhydrous silica; sucrose; magnesium stearate; microcrystalline cellulose; povidone; medium chain triglycerides - tradenames are indicated for the treatment of: ? osteoporosis* in select patients where vitamin d supplementation is recommended,* prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg); colecalciferol, quantity: 0.07 mg - tablet, uncoated - excipient ingredients: gelatin; povidone; croscarmellose sodium; colloidal anhydrous silica; microcrystalline cellulose; medium chain triglycerides; butylated hydroxytoluene; magnesium stearate; sucrose - alendronate plus d3 70 mg/70 microgram apotex are indicated for the treatment of: osteoporosis in select patients where vitamin d supplementation is recommended, prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture

Estados Unidos - inglês - NLM (National Library of Medicine)

bryant ranch prepack - alendronate sodium (unii: 2uy4m2u3ra) (alendronic acid - unii:x1j18r4w8p) - alendronate sodium tablets, usp are indicated for the treatment of osteoporosis in postmenopausal women. in postmenopausal women, alendronate sodium tablets, usp increase bone mass and reduces the incidence of fractures, including those of the hip and spine (vertebral compression fractures). [see clinical studies (14.1).] alendronate sodium tablets, usp are indicated for the prevention of postmenopausal osteoporosis [see clinical studies (14.2)] . alendronate sodium tablets, usp are indicated for treatment to increase bone mass in men with osteoporosis [see clinical studies (14.3)] . alendronate sodium tablets, usp are indicat

Estados Unidos - inglês - NLM (National Library of Medicine)

a-s medication solutions - alendronate sodium (unii: 2uy4m2u3ra) (alendronic acid - unii:x1j18r4w8p) - alendronate sodium tablets, usp are indicated for the treatment of osteoporosis in postmenopausal women. in postmenopausal women, alendronate sodium tablets, usp increase bone mass and reduces the incidence of fractures, including those of the hip and spine (vertebral compression fractures). [see clinical studies (14.1).] alendronate sodium tablets, usp are indicated for the prevention of postmenopausal osteoporosis [see clinical studies (14.2)] . alendronate sodium tablets, usp are indicated for treatment to increase bone mass in men with osteoporosis [see clinical studies (14.3)] . alendronate sodium tablets, usp are indicated for the treatment of glucocorticoid-induced osteoporosis in men and women receiving glucocorticoids in a daily dosage equivalent to 7.5 mg or greater of prednisone and who have low bone mineral density [see clinical studies (14.4)] . alendronate sodium tablets, usp are indicated for the treatment of paget's disease of bone in men and women. treatment is indicated in patients with p

Bélgica - inglês - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pi pharma - alendronate sodium trihydrate - tablet - 70 mg - alendronate sodium trihydrate - alendronic acid

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

apotex nz ltd - alendronate sodium trihydrate 13.05mg equivalent to alendronate 10 mg;   - tablet - 10 mg - active: alendronate sodium trihydrate 13.05mg equivalent to alendronate 10 mg   excipient: magnesium stearate mannitol microcrystalline cellulose - for the treatment of paget's disease of bone in men and women

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

apotex nz ltd - alendronate sodium trihydrate 52.2mg equivalent to alendronate 40 mg;   - tablet - 40 mg - active: alendronate sodium trihydrate 52.2mg equivalent to alendronate 40 mg   excipient: magnesium stearate mannitol microcrystalline cellulose - for the treatment of paget's disease of bone in men and women

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

aurobindo pharma nz limited - alendronate sodium trihydrate 91.363mg equivalent to alendronic acid 70 mg - tablet - 70 mg - active: alendronate sodium trihydrate 91.363mg equivalent to alendronic acid 70 mg excipient: magnesium stearate maize starch microcrystalline cellulose povidone sodium starch glycolate - indicated: in postmenopausal women for the treatment of osteoporosis to prevent fractures, including those of the hip and spine (vertebral compression fractures). for the treatment of osteoporosis in men to prevent fractures.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

apotex nz ltd - alendronate sodium trihydrate 91.37mg equivalent to alendronate 70mg; colecalciferol 140ug (5600 is vitamin d3);   - tablet - 70 mg/140 mcg - active: alendronate sodium trihydrate 91.37mg equivalent to alendronate 70mg colecalciferol 140ug (5600 is vitamin d3)   excipient: colloidal silicon dioxide magnesium stearate mannitol microcrystalline cellulose - indicated for the treatment of osteoporosis in select patients where vitamin d supplementation is recommended.